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Two different components are detected in human amyloid. One soluble compo- 
nent, the so called P component, is immunologically homogeneous (1). The other 
component, the fibril, is more heterogeneous. Fibrils constituted of the variable 
regions of light  immunoglobulin chains are found especially in primary and 
myeloma/macroglobulinemia-associated amyloidosis, while protein AA type fi- 
brils occur primarily in secondary amyloidosis (for nomenclature see 1). 
The occurrence of amyloid is a typical finding in medullary carcinoma of the 
thyroid  (MCT)  (2-4).  This  MCT  amyloid  exhibits  the  characteristics  of all 
amyloids such as affinity for Congo red and green birefringence when studied in 
polarized light. However, there is some evidence for chemical differences from 
most other amyloids (4,  5).  Therefore, we have performed an  antigenic and 
immunochemical analysis of the MCT amyloid and characterized a low molecu- 
lar weight subunit from purified MCT amyloid fibrils. 
Materials and Methods 
Preparation of A myloid Fibrils.  Amyloid-rich lymph node metastases of a  medullary carci- 
noma of the thyroid of a 35-yr-old male patient (F. R.) (5) were used as the main source of amyloid. 
A secondary medullary carcinoma of the thyroid (RO, kindly provided by Doctors R. A. Cook and 
R. Anders) and rich in amyloid was used for further antigenic comparisons. 
For isolation of the P component, the saline washes II-VIII were pooled and used for demonstra- 
tion of P  component (6).  Isolation of amyloid fibril proteins followed a  modification by Wester- 
mark (5) of the method of Pras et al.  (7).  Since the MCT amyloid was more difficult to disolve in 
0.1 M NaOH than most other amyloids, the solution of degraded amyloid fibrils (DAM) was regu- 
larly sonicated. 
Antisera.  Antisera against amyloid protein AA, protein V~,V (AR), void volume (Vo) material, 
and some light chain amyloid proteins (8,  9),  as well as the P  component (6),  were prepared as 
previously described.  Antiserum  against  MCT  amyloid  was  raised  in rabbits using the  DAM 
preparation of MCT amyloid fibril protein FR. Antisera against a variety of K- and ~,-light chains, 
Ig classes, and normal human serum were also used.  (8). 
Gel Filtration.  MCT amyloid fibrils from patient F. R. were dissolved in 6 M guanidine HC1 - 
0.1 M Tris buffer pH 8.0 with 0.1 M dithiothreitol, applied to a 65 x  1.6-cm Sepharose 6B column, 
equilibrated with 5 M  guanidine in H20,  and eluted with the same solution. Suitable fractions 
were  dialyzed  exhaustively against distilled water  in tubings of slightly reduced porosity and 
lyophilized. 
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FIG.  1.  Immunodiffusion of antiserum directed against amyloid of a medullary carcinoma 
(FR)  (central well), against DAM preparations  of two amyloids of medullary carcinomas 
(FR in wells 1 and 4 and RO in well 3), and against AMCT of amyioid FR (well 2). One line of 
precipitation showing antigenic identity is seen. 
Sodium  Dodecyl Sulfate  (SDS) Polyacrylamide Gel Electrophoresis.  SDS electrophoresis was 
performed using the procedure of Swank and Munkres (10). 
Further Analyses.  The proteins were hydrolyzed and  analyzed for amino acids as described 
before (11). Cyanogen bromide cleavage was performed similar to that of Sletten and Husby and 
Tager and Steiner (11, 12). Amino acid sequences were determined by a JEOL-JAS-47K Sequence 
Analyzer (Jeol Company, Tokyo, Japan) and in addition by manual Edman procedure  (11). The 
phenylthiohydantoin  amino acids were identified as described before (11). 
Results 
Immunological  Studies.  When  DAM preparations  of amyloid FR and  RO 
were  tested  in  double  immunodiffusion  against  antiprotein  AA,  antiprotein 
VkV, or antisera  against other known amyloid proteins,  no precipitation lines 
occurred. Neither did anti-K, anti-k, or antihuman normal serum give any lines 
of precipitation.  In contrast,  DAM FR tested with anti-DAM FR absorbed with 
pooled  normal  human  serum  gave  one  line  of precipitation  fusing  with  the 
precipitation lines obtained with the major low molecular weight subunit mate- 
rial of DAM FR (see below) and with the second MCT amyloid, DAM RO (Fig. 
1). 
Absorption of the anti-DAM FR antiserum with pooled normal human serum 
did  not diminish  the  activity of the  antiserum.  However,  some human  sera, 
including  such from patients  with MCT, had the ability to completely abolish 
the lines of precipitation. 
When anti-amyloid  FR antiserum  was tested with DAM preparations  of 15 
systemic  amyloids  of primary  and  secondary types  and  of 5  pancreatic  islet 
amyloids  obtained  from  different  diabetic  patients,  no  lines  of precipitation 
occurred. 
When P-component antiserum was tested against the saline wash material of 
amyloid FR, a line of precipitation occurred which was identical with the line of 
the  saline  wash  material  of a  control  systemic amyloid  and  with  the  line  of 
purified P  component. 0.8  ¢q 
a 
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FXG. 2.  Gel filtration of amyloid fibrils of medullary carcinoma (FR) dissolved in 6 M 
guanidine-0.1 M D'I'F in water on a 65 x 1.6 cm Sepharose 6B column  equilibrated with 
5 M guanidine in water and eluted with the same solution. Horizontal bar indicates the 
fractions that contained protein AMCT (mol wt about 6,000) used for amino acid sequence 
analysis. 
Further Characterization  of the  MCT Arnyloid Protein.  Gel  filtration on 
Sepharose 6B of the amyloid material MCT FR yielded a  major Vo peak and a 
smaller second peak called AMCT (Fig. 2). SDS polyacrylamide gel electrophore- 
sis of AMCT material gave only one band corresponding to a  tool wt of about 
6,000  daltons,  and  this  band  represented  the  major component of the  total 
amyloid material.  Amino acid analysis of the amyloid fibrils,  as well as gel 
filtration fractions 18-26  (V0~), fractions 27-34  (VoH), and fractions 46-51  (AMc  T) 
(Fig. 2), showed a rather similar overall amino acid composition for the amyloid 
fibrils and the AMCT protein,  whereas the Vo material was slightly different 
(Table I). This is in agreement with the results of SDS electrophoresis that the 
main protein of the MCT amyloid fibrils is the protein AMCT. The amino acid 
composition of the protein AMCT was slightly different from calcitonin (Table I), 
but all amino acids in calcitonin, except for threonine and phenylalanine fitted 
into the AMCT protein molecules. The molecular weight of AMCT calculated from 
the amino acid composition (about 5,700) fitted well with that determined by 
SDS  polyacrylamide gel  electrophoresis,  and  indicated about  53  amino acid 
residues of protein AMCT (Table I). 
N-terminal sequence analysis was performed with both the manual procedure 
and  with  the  protein  program  for the  automatic sequence  analyzer.  No  N- 
terminal amino acid could be detected, and when the analyses were continued 
several steps, no amino acid derivatives were obtained. 
Cyanogen bromide cleavage was then carried out. In as much as protein AMCT 
contained only one residue of methionine, the cleavage product was lyophilized 
and applied to the sequence analyzer. The peptide program was used, and the 
sequence was elucidated for 11 residues that should correspond to the N termi- 
nus of  the second cyanogen bromide peptide. They were: Leu-Gly-Thr-Tyr-(Thr)- 
Glx-Asx-Phe-Asx-Lys-Phe-. This sequence corresponds to residues 9-19  in hu- 
man calcitonin which are: Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe  (13). 
The first cyanogen bromide fragment corresponding to the N-terminal-blocked 
fragment was analyzed in SDS polyacrylamide gel electrophoresis, which gave a 
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TABLE  I 
Amino Acid Composition of Amyloid Fractions Obtained from Medullary Carcinoma of 
Thyroid Compared with Calcitonin 
Fibrils 
Residues per I00  Residues per molecule 
VoE  Yon  AMCT  AMCT  Calcitonin 
(ref.  13) 
Asp  10.4  8.80  8.49  9.52  4.74 (5)  3 
Thr  5.45  4.12  3.41  5.59  2.78 (3)  5 
Ser  7.15  6.74  5.59  7.63  3.80 (4)  1 
Glu  12.3  11.3  10.1  13.8  6.88 (7)  2 
Pro  5.7  8.1  8.9  6.3  3.16 (3)  2 
Gly  10.0  21.4  26.7  12.2  6.09 (6)  4 
Ala  7.55  8.47  8.04  9.14  4.55 (5)  2 
1/2Cys  1.6"  1.0"  0.9*  1.6"  0.8* (2)  2 
Val  5.15  3.87  3.51  4.23  2.11 (2)  1 
Met  1.1  0.7  0.6  2.11  1.05 (1)  1 
Ile  3.31  2.93  2.52  2.11  1.05 (1)  1 
Leu  8.24  6.49  5.14  7.93  3.95 (4)  2 
Tyr  4.95  2.95  3.05  0.75  0.35 (1)  1 
Phe  4.8  3,2  3.2  3.0  1.50 (2)  3 
His  1.72  1,08  0.90  2.04  1.02 (1)  1 
Lys  5.08  4,49  3.83  5,59  2.78 (3)  1 
Arg  5.46  4.45  5,05  6.34  3.16 (3)  0 
Number of residues  53  32 
Molecular weight  5,680  3,380 
* Measured as cysteic acid. 
$ Hydrolized without vacuum. 
cyanogen bromide fragment remaining  after 15 Edman degradation steps was 
not detected in the SDS gel,  probably because it was too small (mol wt about 
800). 
Discussion 
The present finding definitely supports the view that the AMC w protein of MCT 
is  unique  and  differs from  other  known  amyloid proteins.  The  antiserum  to 
protein AMCT did not cross-react with any other type of amyloid so far observed, 
and  antisera  to  other  amyloid  preparations  did  not  cross-react  with  DAM 
preparations of MCT amyloid or with its AMCT  protein.  It was also shown that 
protein  AA  and  light  chain  variable  fragments,  which  are  present  in  many 
different amyloids (1), are absent in amyloid of MCT. The MCT amyloid occurs 
only in the vicinity of the tumor cells and seems to be a product of the epithelial 
cells (2, 3). This amyloid resembles in some respects the amyloid of the islets of 
Langerhans  (14), but they do not seem to be identical. 
The AMCT protein is the major protein in the MCT amyloid fibrils. Although 
the elution profile from the gel filtration shows a  relatively small peak of the 
AMCT protein,  this  is  in  agreement  with  the  amino  acid  analysis  and  the 
ultraviolet spectra which revealed a  low content of aromatic  amino  acids.  N- 
terminal  analysis  of the  AMCT  protein  gave  no  free  N  terminal,  but  Edman 
degradation  of the  cyanogen  bromide-treated  material  gave  an  amino  acid 
sequence corresponding to residues 9-19 in calcitonin.  Furthermore,  since the 
mol wt of the AMCT protein was found to be about 5,700 and thus considerably 
larger than  calcitonin,  and the amino  acid composition was similar,  but with 
distinct  differences  from  calcitonin,  there  is  evidence  that  the  AMC  w protein SLETTEN  ET  AL.  BRIEF  DEFINITIVE  REPORT  997 
represents  a  prohormone  for  calcitonin  or  a  fragment of a  precursor.  The 
different amounts of threonine and phenylalanine residues found for AMcv and 
calcitonin may represent genetic variation or be due to a pathological calcitonin: 
It is not unlikely that hormone-related proteins are involved in the formation of 
amyloid fibrils  also  in  other  endocrine  glands  than  the  thyroid,  especially 
insulin-producing tumors and islets of Langerhans where amyloid deposits are 
common. 
Summary 
Amyloid fibrils were studied from two different tissues of medullary carci- 
noma of the thyroid (MCT).  The fibrils mainly consisted of a  low molecular 
weight protein,  AMCT, which was immunologically distinct and did not react 
with various antisera against known amyloid fibril proteins. A specific antise- 
rum raised against the MCT amyloid proteins gave a reaction of identity with 
the degraded MCT amyloid fibrils from two patients, as well as with the isolated 
AMCT protein, but showed no reaction with other known amyloid proteins. The 
AMCT protein had a blocked N terminus, but the sequence analysis of  a cyanogen 
bromide fragment revealed identity with human calcitonin in the 11 positions 
studied.  Although the  amino acid composition was similar,  there were  also 
distinct differences, and the mol wt of  5,700 daltons was considerably larger than 
that of calcitonin. For these reasons the AMCT protein may represent a  prohor- 
mone of calcitonin. 
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